Andorra vs Israel: The number of people with susceptibility test result for rifampicin
Andorra
100
in 2021
Israel
100
in 2021
Andorra rank
2nd
Israel rank
2nd
The number of people with susceptibility test result for rifampicin over time
- Andorra
- Israel
How they compare
Andorra currently reports 100 against 100 in Israel, a difference of 0.
Across all 5 years both countries report, Israel has been ahead every year.
Andorra ranks 2nd and Israel ranks 2nd of 146 countries.
Israel has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Andorra | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.67 | 98.2 | 31.53 | Israel |
| 2020s | 100 | 100 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Andorra or Israel?
- Andorra, at 100 against 100 in Israel as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Andorra and Israel?
- 0, with Andorra ahead.
- How many years of comparable data are there for Andorra and Israel?
- 5 years are reported by both, from 2017 to 2021.
- How do Andorra and Israel rank globally for the number of people with susceptibility test result for rifampicin?
- Andorra ranks 2nd and Israel ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.